Charles River Laboratories Shares Outstanding 2010-2025 | CRL

Charles River Laboratories shares outstanding history from 2010 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Charles River Laboratories shares outstanding for the quarter ending March 31, 2025 were 0.051B, a 1.91% decline year-over-year.
  • Charles River Laboratories 2024 shares outstanding were 0.052B, a 0.34% increase from 2023.
  • Charles River Laboratories 2023 shares outstanding were 0.051B, a 0.29% increase from 2022.
  • Charles River Laboratories 2022 shares outstanding were 0.051B, a 0.24% decline from 2021.
Charles River Laboratories Annual Shares Outstanding
(Millions of Shares)
2024 52
2023 51
2022 51
2021 51
2020 51
2019 50
2018 49
2017 49
2016 48
2015 48
2014 48
2013 48
2012 48
2011 51
2010 63
2009 66
Charles River Laboratories Quarterly Shares Outstanding
(Millions of Shares)
2025-03-31 51
2024-12-31 52
2024-09-30 52
2024-06-30 52
2024-03-31 52
2023-12-31 51
2023-09-30 52
2023-06-30 51
2023-03-31 51
2022-12-31 51
2022-09-30 51
2022-06-30 51
2022-03-31 51
2021-12-31 51
2021-09-30 52
2021-06-30 51
2021-03-31 51
2020-12-31 51
2020-09-30 51
2020-06-30 50
2020-03-31 50
2019-12-31 50
2019-09-30 50
2019-06-30 50
2019-03-31 49
2018-12-31 49
2018-09-30 49
2018-06-30 49
2018-03-31 49
2017-12-31 49
2017-09-30 48
2017-06-30 48
2017-03-31 48
2016-12-31 48
2016-09-30 48
2016-06-30 48
2016-03-31 48
2015-12-31 48
2015-09-30 47
2015-06-30 48
2015-03-31 48
2014-12-31 48
2014-09-30 47
2014-06-30 48
2014-03-31 48
2013-12-31 48
2013-09-30 48
2013-06-30 49
2013-03-31 48
2012-12-31 48
2012-09-30 48
2012-06-30 48
2012-03-31 49
2011-12-31 51
2011-09-30 51
2011-06-30 52
2011-03-31 55
2010-12-31 63
2010-09-30 63
2010-06-30 66
2010-03-31 66
2009-12-31 66
2009-09-30 65
2009-06-30 65
2009-03-31 66
Sector Industry Market Cap Revenue
Medical Medical Services $7.762B $4.050B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $141.524B 26.54
CVS Health (CVS) United States $81.417B 10.12
Elevance Health (ELV) United States $76.834B 9.91
Cencora (COR) United States $57.577B 20.03
DiDi Global (DIDIY) China $25.180B 26.75
Natera (NTRA) United States $21.599B 0.00
Labcorp Holdings (LH) United States $20.908B 16.96
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.318B 0.00
CochLear (CHEOY) Australia $13.009B 0.00
Solventum (SOLV) United States $12.815B 13.57
ICON (ICLR) Ireland $12.075B 11.23
Revvity (RVTY) United States $11.607B 19.97
Viatris (VTRS) United States $10.727B 3.69
Medpace Holdings (MEDP) United States $9.208B 24.45
Avantor (AVTR) United States $9.009B 13.09
Sonic Healthcare (SKHHY) Australia $8.842B 0.00
HealthEquity (HQY) United States $8.418B 36.87
Caris Life Sciences,�Inc (CAI) United States $7.052B 0.00
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.840B 28.50
BrightSpring Health Services (BTSG) United States $3.571B 32.76
Sotera Health (SHC) United States $3.296B 18.73
Surgery Partners (SGRY) United States $2.880B 37.45
Alignment Healthcare (ALHC) United States $2.651B 0.00
Concentras Parent (CON) United States $2.593B 14.98
Organon (OGN) United States $2.550B 2.71
GeneDx Holdings (WGS) United States $2.351B 90.54
Ardent Health (ARDT) United States $2.073B 8.84
Progyny (PGNY) United States $2.012B 44.28
PACS (PACS) United States $1.966B 0.00
Premier (PINC) United States $1.750B 13.28
GoodRx Holdings (GDRX) United States $1.725B 34.50
Teladoc Health (TDOC) United States $1.451B 0.00
Establishment Labs Holdings (ESTA) $1.316B 0.00
Pediatrix Medical (MD) United States $1.131B 8.60
CareDx (CDNA) United States $1.115B 17.41
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
Agilon Health (AGL) United States $0.931B 0.00
QDM (QDMI) Hong Kong, SAR China $0.848B 291.00
AMN Healthcare Services Inc (AMN) United States $0.791B 7.41
Nutex Health (NUTX) United States $0.645B 9.76
Embecta (EMBC) United States $0.606B 4.08
InnovAge Holding (INNV) United States $0.582B 0.00
SBC Medicals (SBC) United States $0.518B 0.00
LifeMD (LFMD) United States $0.514B 0.00
Sonida Senior Living (SNDA) United States $0.487B 0.00
Auna S.A (AUNA) Luxembourg $0.473B 10.65
Omada Health (OMDA) $0.452B 0.00
So-Young (SY) China $0.430B 0.00
Enhabit (EHAB) United States $0.359B 29.50
COMPASS Pathways (CMPS) United Kingdom $0.347B 0.00
Performant Healthcare (PHLT) United States $0.331B 0.00
Oncology Institute (TOI) United States $0.286B 0.00
Beauty Health (SKIN) United States $0.236B 0.00
DocGo (DCGO) United States $0.149B 24.33
Pheton Holdings (PTHL) China $0.142B 0.00
Sera Prognostics (SERA) United States $0.104B 0.00
Ascend Wellness Holdings (AAWH) United States $0.078B 0.00
KindlyMD (NAKA) United States $0.073B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.060B 0.00
Basel Medical Group (BMGL) Singapore $0.056B 0.00
ModivCare (MODV) United States $0.047B 0.00
Biodesix (BDSX) United States $0.046B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.036B 0.00
OSR Holdings (OSRH) United States $0.022B 0.00
Intelligent Bio Solutions (INBS) United States $0.012B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
SeaStar Medical Holding (ICU) United States $0.006B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00